FDA Gives Preliminary Nod To Cipla And Sun Drugs

by Medindia Content Team on  May 23, 2006 at 6:16 PM Corporate News
RSS Email Print This Page Comment
Font : A-A+

FDA Gives Preliminary Nod To Cipla And Sun Drugs
A U.S. Food and Drug Administration statement has said that drug maker Cipla Ltd. has been given tentative approval for its generic AIDS drug nevirapine that is to be marketed in a tablet form.

Sun Pharma Ltd has also received similar approval for ondansetron in the injection form.

Ondansetron is used to prevent of nausea and vomiting following chemotherapy or radiation therapy for cancer. The drug is the generic equivalent of GlaxoSmithKline's Zofran injection.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive